App designed to track macular degeneration triumphs in clinical trial
Clinical Trials Arena January 23, 2024
The study was designed to assess the equivalence of visual acuity measurements between Tilak Healthcare’s OdySight app, and traditional eyesight checks.
TIL002, a multicentre trial taking place across three French hospitals, demonstrated that theCE-marked OdySight app showed a high level of concordance between itself and traditional methods of testing for eyesight decline.
The app allows patients to carry out regular monitoring of their visual acuity through eye tests that they perform themselves, with the results forwarded to the patient’s clinicians.